Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Detecting bliss synergy in in vivo combination studies with a tumor kinetic model.

Zhao W, Vicini P, Novick S, Anderton J, Davies G, DAngelo G, O'Day T, Yu B, Harper J, Narwal R, Roskos L, Yang H.

Pharm Stat. 2019 May 29. doi: 10.1002/pst.1952. [Epub ahead of print]

PMID:
31140720
2.

CD4+ T Cells Drive Lung Disease Enhancement Induced by Immunization with Suboptimal Doses of Respiratory Syncytial Virus Fusion Protein in the Mouse Model.

Schneider-Ohrum K, Snell Bennett A, Rajani GM, Hostetler L, Maynard SK, Lazzaro M, Cheng LI, O'Day T, Cayatte C.

J Virol. 2019 Jul 17;93(15). pii: e00695-19. doi: 10.1128/JVI.00695-19. Print 2019 Aug 1.

PMID:
31092578
3.

Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.

Cayatte C, Snell Bennett A, Rajani GM, Hostetler L, Maynard SK, Lazzaro M, McTamney P, Ren K, O'Day T, McCarthy MP, Schneider-Ohrum K.

PLoS One. 2017 Nov 28;12(11):e0188708. doi: 10.1371/journal.pone.0188708. eCollection 2017.

4.

Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.

Trevaskis JL, Sacramento CB, Jouihan H, Ali S, Le Lay J, Oldham S, Bhagroo N, Boland BB, Cann J, Chang Y, O'Day T, Howard V, Reers C, Winzell MS, Smith DM, Feigh M, Barkholt P, Schreiter K, Austen M, Andag U, Thompson S, Jermutus L, Coghlan MP, Grimsby J, Dohrmann C, Rhodes CJ, Rondinone CM, Sharma A.

Diabetes. 2017 Jul;66(7):2007-2018. doi: 10.2337/db16-0916. Epub 2017 Apr 13.

5.

Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.

Schneider-Ohrum K, Cayatte C, Bennett AS, Rajani GM, McTamney P, Nacel K, Hostetler L, Cheng L, Ren K, O'Day T, Prince GA, McCarthy MP.

J Virol. 2017 Mar 29;91(8). pii: e02180-16. doi: 10.1128/JVI.02180-16. Print 2017 Apr 15.

6.

Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.

Le VT, Tkaczyk C, Chau S, Rao RL, Dip EC, Pereira-Franchi EP, Cheng L, Lee S, Koelkebeck H, Hilliard JJ, Yu XQ, Datta V, Nguyen V, Weiss W, Prokai L, O'Day T, Stover CK, Sellman BR, Diep BA.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5640-8. doi: 10.1128/AAC.00710-16. Print 2016 Oct.

7.

Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections.

Cohen TS, Hilliard JJ, Jones-Nelson O, Keller AE, O'Day T, Tkaczyk C, DiGiandomenico A, Hamilton M, Pelletier M, Wang Q, Diep BA, Le VT, Cheng L, Suzich J, Stover CK, Sellman BR.

Sci Transl Med. 2016 Mar 9;8(329):329ra31. doi: 10.1126/scitranslmed.aad9922.

PMID:
26962155
8.

Members take action to reduce effects of climate change.

O'Day T, Wallace C.

Am Nurse. 2015 Sep-Oct;47(5):13. No abstract available.

PMID:
26563053
9.

Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

Hilliard JJ, Datta V, Tkaczyk C, Hamilton M, Sadowska A, Jones-Nelson O, O'Day T, Weiss WJ, Szarka S, Nguyen V, Prokai L, Suzich J, Stover CK, Sellman BR.

Antimicrob Agents Chemother. 2015 Jan;59(1):299-309. doi: 10.1128/AAC.03918-14. Epub 2014 Oct 27.

10.

Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia.

Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, Keller A, O'Day T, Du Q, Cheng L, Damschroder M, Robbie G, Suzich J, Stover CK, Sellman BR.

Antimicrob Agents Chemother. 2014;58(2):1108-17. doi: 10.1128/AAC.02190-13. Epub 2013 Dec 2.

11.

Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model.

Tkaczyk C, Hamilton MM, Datta V, Yang XP, Hilliard JJ, Stephens GL, Sadowska A, Hua L, O'Day T, Suzich J, Stover CK, Sellman BR.

PLoS One. 2013 Oct 2;8(10):e75103. doi: 10.1371/journal.pone.0075103. eCollection 2013.

12.

Environmental monitoring: setting alert and action limits based on a zero-inflated model.

Yang H, Zhao W, O'day T, Fleming W.

PDA J Pharm Sci Technol. 2013 Jan-Feb;67(1):2-8. doi: 10.5731/pdajpst.2013.00897.

PMID:
23385559
13.

Validation of the Health-Promoting Lifestyle Profile II for Hispanic male truck drivers in the Southwest.

Mullins IL, O'Day T, Kan TY.

Clin Nurs Res. 2013 Aug;22(3):375-94. doi: 10.1177/1054773812459072. Epub 2012 Oct 8.

PMID:
23047981
14.

Concealed carry: best practices after November 1, 2011.

Shorter TN, O'Day T.

WMJ. 2011 Dec;110(6):297-8. No abstract available.

15.

Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.

Reay DP, Yang M, Watchko JF, Daood M, O'Day TL, Rehman KK, Guttridge DC, Robbins PD, Clemens PR.

Neurobiol Dis. 2011 Sep;43(3):598-608. doi: 10.1016/j.nbd.2011.05.008. Epub 2011 May 23.

16.

Disaster response: the University of Texas School of Nursing experience.

Pattillo MM, O'Day TM.

Nurs Health Sci. 2009 Dec;11(4):378-81. doi: 10.1111/j.1442-2018.2009.00500.x.

PMID:
19909445
17.

Full-length dystrophin gene transfer to the mdx mouse in utero.

Reay DP, Bilbao R, Koppanati BM, Cai L, O'Day TL, Jiang Z, Zheng H, Watchko JF, Clemens PR.

Gene Ther. 2008 Apr;15(7):531-6. doi: 10.1038/gt.2008.8. Epub 2008 Feb 14.

PMID:
18273052
18.

Unconjugated bilirubin efflux by bovine brain microvascular endothelial cells in vitro.

Sequeira D, Watchko JF, Daood MJ, O'Day TL, Mahmood B.

Pediatr Crit Care Med. 2007 Nov;8(6):570-5.

PMID:
17906594
19.

Sex-specific regional brain bilirubin content in hyperbilirubinemic Gunn rat pups.

Cannon C, Daood MJ, O'Day TL, Watchko JF.

Biol Neonate. 2006;90(1):40-5. Epub 2006 Mar 3.

PMID:
16534185
20.

Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.

Watchko J, O'Day T, Wang B, Zhou L, Tang Y, Li J, Xiao X.

Hum Gene Ther. 2002 Aug 10;13(12):1451-60.

PMID:
12215266
21.

Functional characteristics of dystrophic skeletal muscle: insights from animal models.

Watchko JF, O'Day TL, Hoffman EP.

J Appl Physiol (1985). 2002 Aug;93(2):407-17. Review.

22.

Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.

Mueller GM, O'Day T, Watchko JF, Ontell M.

Hum Gene Ther. 2002 Jun 10;13(9):1081-90.

PMID:
12067441
23.

Chloroprocaine is less painful than lidocaine for skin infiltration anesthesia.

Marica LS, O'Day T, Janosky JE, Nystrom EU.

Anesth Analg. 2002 Feb;94(2):351-4, table of contents.

PMID:
11812697
24.

Respiratory modulation of genioglossal activity.

Watchko JF, O'Day TL, Guthrie RD.

Anesth Analg. 1993 Jul;77(1):199-200. No abstract available.

PMID:
8317738
25.

Effect of undernutrition on contractile and fatigue properties of rat diaphragm during development.

Brozanski BS, Watchko JF, O'Day TL, Guthrie RD.

J Appl Physiol (1985). 1993 May;74(5):2121-6.

PMID:
8335538
26.

Contractile properties of the rat external abdominal oblique and diaphragm muscles during development.

Watchko JF, Brozanski BS, O'Day TL, Guthrie RD, Sieck GC.

J Appl Physiol (1985). 1992 Apr;72(4):1432-6.

PMID:
1592735
27.

Control of genioglossal muscle activity in the anesthetized piglet: the role of vagal afferents.

Watchko JF, O'Day TL, Brozanski BS, Vazquez RL, Guthrie RD.

Biol Neonate. 1992;61(6):366-73.

PMID:
1525270
28.

Diaphragmatic electromyogram power-spectral analysis as a function of reduced end-expiratory lung volume.

Lantzy A, O'Day TL, Vazquez RL, Guthrie RD, Watchko JF.

Pediatr Res. 1991 Dec;30(6):606-9.

PMID:
1805158
29.

Practical anterior segment fluorescein angiography.

Fariza E, Ormerod LD, O'Day T, Celorio JM.

Graefes Arch Clin Exp Ophthalmol. 1991;229(2):105-10.

PMID:
2044967
30.

Expiratory abdominal muscle activity during ventilatory chemostimulation in piglets.

Watchko JF, O'Day TL, Brozanski BS, Guthrie RD.

J Appl Physiol (1985). 1990 Apr;68(4):1343-9.

PMID:
2140826
31.

External intercostal muscle activity during acute hypoxia in the kitten.

Guthrie RD, Klesh KW, O'Day TL, Watchko JF.

Pediatr Pulmonol. 1990;9(4):233-7.

PMID:
2124346
32.

Use of cross-polarized light in anterior segment photography.

Fariza E, O'Day T, Jalkh AE, Medina A.

Arch Ophthalmol. 1989 Apr;107(4):608-10.

PMID:
2705935
33.

Costal and crural diaphragm, and intercostal and genioglossal electromyogram activities during spontaneous augmented breaths (sighs) in kittens.

Watchko JF, Brozanski BS, O'Day TL, Klesh KW, Guthrie RD.

Pediatr Pulmonol. 1989;7(2):94-100.

PMID:
2797926
34.

Genioglossal recruitment during acute hypoxia and hypercapnia in kittens.

Watchko JF, Klesh KW, O'Day TL, Weiss MG, Guthrie RD.

Pediatr Pulmonol. 1989;7(4):235-43.

PMID:
2616247
35.

Use of circularly polarized light in fundus and optic disc photography.

Fariza E, Jalkh AE, Thomas JV, O'Day T, Peli E, Acosta J.

Arch Ophthalmol. 1988 Jul;106(7):1001-4.

PMID:
3390038
36.

Recruitment of intercostal muscle activity during hypercapnia in kittens.

Watchko JF, Klesh KW, O'Day TL, Guthrie RD.

Pediatr Pulmonol. 1988;5(4):215-9.

PMID:
3148900
37.

Tort reform controversy in perspective: differing views from the grass roots. Panel discussion.

Lehtinen DW, Kussman RS, O'Day TA, Waxman JM.

Rev Fed Am Health Syst. 1987 Nov-Dec;20(6):35-9. No abstract available.

PMID:
10285109
38.

A second example of autoanti-Jk3.

O'Day T.

Transfusion. 1987 Sep-Oct;27(5):442. No abstract available.

PMID:
3629677
39.

Gerbich (Ge) antibody classification using enzyme-treated red cells.

Mohammed MT, O'Day T, Sugasawara E.

Transfusion. 1986 Jan-Feb;26(1):120. No abstract available.

PMID:
3511571
40.

Use of a modified procedure for treating small amounts of red blood cells with 2-aminoethylisothiouronium bromide.

Ellisor SS, O'Day T, Reid ME, Arndt L, Sugasawara E.

Am J Clin Pathol. 1984 Oct;82(4):439-41.

PMID:
6206714
41.

Supplemental Content

Support Center